Glycine transporters type 1 inhibitor promotes brain preconditioning against NMDA-induced excitotoxicity

[1]  R. Resende,et al.  Sarcosine preconditioning induces ischemic tolerance against global cerebral ischemia , 2014, Neuroscience.

[2]  Rita I Aroeira,et al.  GlyT1 and GlyT2 in brain astrocytes: expression, distribution and function , 2014, Brain Structure and Function.

[3]  R. Resende,et al.  Neurochemical study of amino acids in rodent brain structures using an improved gas chromatography–mass spectrometry method , 2014, Journal of Chemical Neuroanatomy.

[4]  D. Javitt,et al.  Effects of novel, high affinity glycine transport inhibitors on frontostriatal dopamine release in a rodent model of schizophrenia , 2012, European Neuropsychopharmacology.

[5]  A. R. Massensini,et al.  Pharmacological induction of ischemic tolerance in hippocampal slices by sarcosine preconditioning , 2012, Neurochemistry International.

[6]  S. Oliet,et al.  Synaptic and Extrasynaptic NMDA Receptors Are Gated by Different Endogenous Coagonists , 2012, Cell.

[7]  P. Kind,et al.  The Subtype of GluN2 C-terminal Domain Determines the Response to Excitotoxic Insults , 2012, Neuron.

[8]  D. Meaney,et al.  NR2A and NR2B subunits differentially mediate MAP kinase signaling and mitochondrial morphology following excitotoxic insult , 2012, Neurochemistry International.

[9]  M. Miranda,et al.  PKCβ-dependent phosphorylation of the glycine transporter 1 , 2011, Neurochemistry International.

[10]  A. Ortiz,et al.  Molecular basis of the differential interaction with lithium of glycine transporters GLYT1 and GLYT2 , 2011, Journal of neurochemistry.

[11]  M. Tanabe,et al.  Increased hippocampal glycine uptake and cognitive dysfunction after peripheral nerve injury , 2011, PAIN®.

[12]  Yunman Li,et al.  Astrocytic glutamate transporter-dependent neuroprotection against glutamate toxicity: an in vitro study of maslinic acid. , 2011, European journal of pharmacology.

[13]  F. Zafra,et al.  P2Y Purinergic Regulation of the Glycine Neurotransmitter Transporters* , 2011, The Journal of Biological Chemistry.

[14]  S. Teague,et al.  Glycine transporter 1 (GlyT1) inhibitors exhibit anticonvulsant properties in the rat maximal electroshock threshold (MEST) test , 2010, Brain Research.

[15]  P. Wlaź,et al.  Effects of sarcosine, a glycine transporter type 1 inhibitor, in two mouse seizure models , 2010, Pharmacological reports : PR.

[16]  A. Lyons-Warren,et al.  The glycine transport inhibitor sarcosine is an inhibitory glycine receptor agonist , 2009, Neuropharmacology.

[17]  Yuko Fujita,et al.  Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the glycine transporter-1 inhibitor NFPS and d-serine , 2008, European Neuropsychopharmacology.

[18]  L. Raiteri,et al.  Glycinergic nerve endings in hippocampus and spinal cord release glycine by different mechanisms in response to identical depolarizing stimuli , 2008, Journal of neurochemistry.

[19]  Shijie Jin,et al.  Excitatory amino acid transporter expression by astrocytes is neuroprotective against microglial excitotoxicity , 2008, Brain Research.

[20]  F. Jirik,et al.  Prion protein attenuates excitotoxicity by inhibiting NMDA receptors , 2008, The Journal of cell biology.

[21]  M. Raiteri,et al.  Functional expression of release-regulating glycine transporters GLYT1 on GABAergic neurons and GLYT2 on astrocytes in mouse spinal cord , 2008, Neurochemistry International.

[22]  M. Constantine‐Paton,et al.  NR2A−/− Mice Lack Long-Term Potentiation But Retain NMDA Receptor and L-Type Ca2+ Channel-Dependent Long-Term Depression in the Juvenile Superior Colliculus , 2007, The Journal of Neuroscience.

[23]  G. Bellenchi,et al.  The Transporters GlyT2 and VIAAT Cooperate to Determine the Vesicular Glycinergic Phenotype , 2007, The Journal of Neuroscience.

[24]  J. Lipski,et al.  Neuroprotective potential of ceftriaxone in in vitro models of stroke , 2007, Neuroscience.

[25]  J. Roh,et al.  Pharmacological Induction of Ischemic Tolerance by Glutamate Transporter-1 (EAAT2) Upregulation , 2007, Stroke.

[26]  O. Hurtado,et al.  TNFR1 mediates increased neuronal membrane EAAT3 expression after in vivo cerebral ischemic preconditioning , 2006, Neuroscience.

[27]  N. Hardingham,et al.  Preconditioning Doses of NMDA Promote Neuroprotection by Enhancing Neuronal Excitability , 2006, The Journal of Neuroscience.

[28]  Robert W. McCarley,et al.  A Pharmacological Model for Psychosis Based on N-methyl-D-aspartate Receptor Hypofunction: Molecular, Cellular, Functional and Behavioral Abnormalities , 2006, Biological Psychiatry.

[29]  D. Pei,et al.  Neuroprotective Effects of Preconditioning Ischemia on Ischemic Brain Injury through Down-regulating Activation of JNK1/2 via N-Methyl-D-aspartate Receptor-mediated Akt1 Activation* , 2005, Journal of Biological Chemistry.

[30]  B. Cubelos,et al.  Localization of the GLYT1 glycine transporter at glutamatergic synapses in the rat brain. , 2005, Cerebral cortex.

[31]  R. Lim,et al.  Blockade of glycine transporter-1 (GLYT-1) potentiates NMDA receptor-mediated synaptic transmission in hypoglossal motorneurons. , 2004, Journal of neurophysiology.

[32]  G. Collingridge,et al.  Differential Roles of NR2A and NR2B-Containing NMDA Receptors in Cortical Long-Term Potentiation and Long-Term Depression , 2004, The Journal of Neuroscience.

[33]  K. Roche,et al.  Subunit-Specific Regulation of NMDA Receptor Endocytosis , 2004, The Journal of Neuroscience.

[34]  C. Boeck,et al.  NMDA Preconditioning Protects against Seizures and Hippocampal Neurotoxicity Induced by Quinolinic Acid in Mice , 2004, Epilepsia.

[35]  J. Brotchie,et al.  Cannabinoids Decrease Corticostriatal Synaptic Transmission via an Effect on Glutamate Uptake , 2003, The Journal of Neuroscience.

[36]  P. Mallorga,et al.  Pharmacology and expression analysis of glycine transporter GlyT1 with [3H]-(N-[3-(4′-fluorophenyl)-3-(4′phenylphenoxy)propyl])sarcosine , 2003, Neuropharmacology.

[37]  P. Mallorga,et al.  The Glycine Transporter Type 1 Inhibitor N-[3-(4′-Fluorophenyl)-3-(4′-Phenylphenoxy)Propyl]Sarcosine Potentiates NMDA Receptor-Mediated Responses In Vivo and Produces an Antipsychotic Profile in Rodent Behavior , 2003, The Journal of Neuroscience.

[38]  Yasuhiro Yamamoto,et al.  In vivo neuroprotective role of NMDA receptors against kainate‐induced excitotoxicity in murine hippocampal pyramidal neurons , 2003, Journal of neurochemistry.

[39]  W. Ju,et al.  Glycine binding primes NMDA receptor internalization , 2003, Nature.

[40]  É. Schmidt,et al.  The glycine transporter-1 inhibitors NFPS and Org 24461: a pharmacological study , 2003, Pharmacology Biochemistry and Behavior.

[41]  Charles R. Yang,et al.  Glycine tranporter-1 blockade potentiates NMDA-mediated responses in rat prefrontal cortical neurons in vitro and in vivo. , 2003, Journal of neurophysiology.

[42]  R. Vandenberg,et al.  N[3‐(4′‐fluorophenyl)‐3‐(4′‐phenylphenoxy)propyl]sarcosine (NFPS) is a selective persistent inhibitor of glycine transport , 2001, British journal of pharmacology.

[43]  K. Johnson,et al.  Mechanisms of N-methyl-D-aspartate-induced apoptosis in phencyclidine-treated cultured forebrain neurons. , 2000, The Journal of pharmacology and experimental therapeutics.

[44]  K. Johnson,et al.  Chronic phencyclidine increases NMDA receptor NR1 subunit mRNA in rat forebrain , 1999, Journal of neuroscience research.

[45]  J. Coyle,et al.  Modulation of N-methyl-D-aspartate receptor function by glycine transport. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[46]  S. Vicini,et al.  Increased contribution of NR2A subunit to synaptic NMDA receptors in developing rat cortical neurons , 1998, The Journal of physiology.

[47]  J Kerby,et al.  Pharmacological properties of recombinant human N-methyl-D-aspartate receptors comprising NR1a/NR2A and NR1a/NR2B subunit assemblies expressed in permanently transfected mouse fibroblast cells. , 1995, Molecular pharmacology.

[48]  J. Gomeza,et al.  Regional Distribution and Developmental Variation of the Glycine Transporters GLYT1 and GLYT2 in the Rat CNS , 1995, The European journal of neuroscience.

[49]  J. Storm-Mathisen,et al.  Glycine transporters are differentially expressed among CNS cells , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[50]  D. Laurie,et al.  Ligand affinities at recombinant N-methyl-D-aspartate receptors depend on subunit composition. , 1994, European journal of pharmacology.